Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells
- PMID: 2477443
Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells
Abstract
The effector mechanism of skin allograft rejection has been characterized as Ag specific, rejecting cells that express the target alloantigen but sparing those that do not. However, the rejection of MHC class II disparate skin grafts, in which very few cells (Langerhans cells) actually express the target Ia Ag could conceivably proceed by either one of two distinct rejection mechanisms. One possibility is that Ia- cells are destroyed by a sequence of events in which CD4+ T cells, activated by Ia+ LC, elaborate soluble factors that are either directly cytolytic or that recruit and activate non-specific effector cells. The alternative possibility is that activated CD4+ T cells elaborate soluble factors which induce Ia expression on Ia- cell populations, and that these Ia+ cells are subsequently destroyed by effector cells specific for the induced Ia alloantigens. We found that rejection of Ia+ LC was not of itself sufficient to cause rejection of skin grafts, indicating that skin allograft rejection is contingent on the destruction not only of LC but of other graft cell populations as well. We then investigated whether CD4+ T cells rejected allogeneic skin grafts in an antigen specific fashion. To do so, we engrafted immunoincompetent H-2b nude mice with trunk skin grafts from B6----A/J allophenic mice because such skin is composed of mutually exclusive cell populations expressing either H-2a or H-2b histocompatibility Ag, but not both. The engrafted mice were subsequently reconstituted with H-2b CD4+ T cells. The CD4+ T cells destroyed keratinocytes of A/J origin but spared keratinocytes of B6 origin, even though neither cell population constitutively expresses target IAk alloantigen. The targeted rejection of A/J keratinocytes but not of B6 keratinocytes indicates that the target Ia alloantigen must have been induced on Ia- A/J keratinocytes, rendering them susceptible to destruction by anti-Iak-specific CD4+ effector cells. These data demonstrate that CD4+ T cell rejection of skin allografts is mediated by Ag-specific CD4+ cytolytic T cells and hence, requires the induction of target Ia alloantigens on epidermal cells within the graft.
Similar articles
-
Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.J Immunol. 1990 Mar 15;144(6):2425-35. J Immunol. 1990. PMID: 1968930
-
Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.J Immunol. 1986 Jun 15;136(12):4362-71. J Immunol. 1986. PMID: 3519767
-
Immune mechanisms of tissue destruction in vivo.Princess Takamatsu Symp. 1988;19:209-14. Princess Takamatsu Symp. 1988. PMID: 2908354
-
Processed MHC class I alloantigen as the stimulus for CD4+ T-cell dependent antibody-mediated graft rejection.Immunol Today. 1992 Nov;13(11):434-8. doi: 10.1016/0167-5699(92)90069-J. Immunol Today. 1992. PMID: 1362058 Review.
-
Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction.Annu Rev Immunol. 1992;10:333-58. doi: 10.1146/annurev.iy.10.040192.002001. Annu Rev Immunol. 1992. PMID: 1590990 Review.
Cited by
-
Mechanism of the rejection of major histocompatibility complex class I-disparate murine skin grafts: rejection can be mediated by CD4+ cells activated by allo-class I + II antigen in CD8+ cell-depleted hosts.J Exp Med. 1992 Aug 1;176(2):617-21. doi: 10.1084/jem.176.2.617. J Exp Med. 1992. PMID: 1354244 Free PMC article.
-
IN TIME: THE VALUE AND GLOBAL IMPLICATIONSOF NEWBORN SCREENING FORSEVERE COMBINED IMMUNODEFICIENCY.Rev Paul Pediatr. 2018 Oct-Dec;36(4):388-397. doi: 10.1590/1984-0462/;2018;36;4;00020. Rev Paul Pediatr. 2018. PMID: 30540106 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Research Materials